Respected Medical Geneticist Sir Peter Harper Dies at 81

The Cardiff University researcher was famous both for his work on genetic disorders and for his documentation of the history of his field.

Written byCatherine Offord
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: Peter Harper (left) was welcomed into the Learned Society of Wales by Welsh chemist John Cadogan in 2011.
COURTESY OF THE LEARNED SOCIETY OF WALES

Sir Peter Stanley Harper, an influential British geneticist who authored several popular books on the ethics and history of medical genetics, died January 23. He was 81 years old.

Known for his work on myotonic dystrophy and Huntington’s disease, Harper became a widely respected voice in the field of medical genetics in the late 20th century, tackling both the technical aspects of molecular diagnosis and the social implications of using such approaches in the clinic.

“Peter’s impact in clinical genetics was colossal,” reads a statement posted on Twitter by the All Wales Medical Genomics Service, a genetic testing and counseling service that Harper helped develop during his decades-long career at the University of Wales College of Medicine (now merged with Cardiff University). “His work has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies